Triad Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3M Sell
11,330
-262
-2% -$69.1K 0.17% 86
2026
Q2
$2.95M Buy
11,592
+1,833
+19% +$427K 0.17% 89
2026
Q1
$2.39M Buy
9,759
+2,518
+35% +$587K 0.19% 90
2025
Q4
$1.5M Buy
7,241
+918
+15% +$182K 0.14% 107
2025
Q3
$1.17M Sell
6,323
-46
-0.7% -$7.88K 0.15% 106
2025
Q2
$973K Buy
6,369
+2,667
+72% +$410K 0.2% 90
2025
Q1
$614K Buy
3,702
+624
+20% +$97.6K 0.19% 89
2024
Q4
$445K Buy
+3,078
New +$477K 0.16% 98
2024
Q3
– Sell
-2,210
Closed -$323K – 491
2024
Q2
$323K Buy
2,210
+351
+19% +$52.2K 0.17% 59
2024
Q1
$294K Buy
+1,859
New +$296K 0.23% 43

Other funds holding JNJ

Triad Wealth Partners's JNJ Position: Q3 2026 in Review

Triad Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 2.3% in Q3 2026, selling an estimated $69.1K and leaving 11,330 shares worth $3M. The position accounts for 0.17% of the portfolio, ranked #86.

Triad Wealth Partners first reported a position in JNJ in Q1 2024 and has held it in 10 quarters since. 4,662 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Triad Wealth Partners held 11,330 shares of Johnson & Johnson worth $3M as of Q3 2026.
  • Triad Wealth Partners sold 262 Johnson & Johnson shares in Q3 2026, an estimated $69.1K.
  • Johnson & Johnson made up 0.17% of Triad Wealth Partners's portfolio in Q3 2026, its #86 holding.
  • Triad Wealth Partners first reported a position in Johnson & Johnson in Q1 2024 and has held it in 10 quarters since.
  • 4,662 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Triad Wealth Partners's 13F filing for Q3 2026, filed 26 Oct 2026.